Table 2.
Problem | Established approaches | Experimental approaches |
---|---|---|
Scenario 1: test not done, fever treated presumptively | ||
RDT shortages | - | Using technology such as short text messaging (SMS), internet, and electronic mapping to track stock of RDTs 20 21 |
Limited RDT availability in private drug retail sector | - | Provision of free or subsidised RDTs through the private sector22 23 |
Staff shortages and high patient load in health centres | Use of community health workers to diagnose and treat uncomplicated malaria24 25 | - |
Scenario 2: test positive but the result is a false positive | ||
Low specificity of tests | Regular quality testing of RDTs from manufacturers by WHO26 | Enabling external QA of reading and interpretation of RDTs by sending test photographs via SMS11 |
Urine or fluorescent RDTs27 | ||
Scenario 3: test negative; but antimalarial drugs are still prescribed | ||
Uncertainty about RDT accuracy and perceived risk of mortality in people with false negatives results | Interactive educational meetings28 Multifaceted interventions including health workers, patients and the public 28 29 30 |
Evidence based training on the accuracy of RDTs and safety of not treating when results are negative31 32 |
Accessible formats for guidelines, e.g. summaries33 | Electronic or mobile friendly guidelines34 | |
Uncertainty about how to manage fever when test is negative | Integrated case management of malarial and non-malarial causes of fever24 25 | Improving referral paths for patients with negative results35 |
Expectation that patients will seek treatment elsewhere | Mass media interventions38 | Incorporating patient communication skills in training packages of health workers32 36 |
Use of clinic posters, decision aids and patient pamphlets and community awareness programmes32 36 | ||
SMS reminders reiterating the treatment advice based on RDT result37 |